Advertisement

Topics

Pevion Biotech AG Company Profile

01:44 EST 23rd February 2019 | BioPortfolio

Pevion Biotech AG is a fully independent Swiss vaccine company that develops innovative vaccines for unmet medical needs based on its clinically and commercially validated virosome technology. Its proprietary clinical pipeline includes a first-in-class candidiasis vaccine. A clinical stage malaria vaccine candidate has been successfully out-licensed, and the Company’s technology has been out-licensed for use as an HIV vaccine currently in human trials. Pevion has in-house development capability and expertise, including a state-of-the-art and industrially scalable GMP manufacturing process. Located near Bern, Pevion was established by two founding companies, Bachem AG (SWX: BANB) and Berna Biotech (now Crucell, a Johnson & Johnson subsidiary). To date, Pevion has raised a total of CHF 45 million from its founders and investors, BZ Bank, Bachem, BB Biotech Ventures and private investors.

Location

Worblentalstrasse 32
Ittigen
Bern
Schweiz
CH-3063
Switzerland

Contact

Phone: +41 31 550 44 44
Fax: +41 31 550 44 45
Email: info@pevion.com


News Articles [1516 Associated News Articles listed on BioPortfolio]

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years ...

How big is the gap between biotech and digital investments?

Many people outside of biotech may wonder how the size of the biotech industry compares to the digital industry, and even biotech experts often don’t know the answer. Here we’ll take a look at how...

VIDEO: Biotech Showcase 2019: F2G Accelerates Phase IIb Program Vs Life-Threatening Fungal Infections

Ian Nicholson, CEO of F2G, updated Mike Ward during Biotech Showcase 2019 on the progress the biotech company is having...   

PCI Biotech Holding ASA: PCI Biotech: Disclosure of voting rights for Chairman of the Board

Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and ....

VIDEO: Biotech Showcase 2019: Rexgenero Advances CLI-Focused Regenerative Medicine Into Phase III

Joe Dupere, CEO at Rexgenero, reveals to Mike Ward during Biotech Showcase 2019 the four-year-old UK biotech’s plans.    

How Big is the Investment Gap Between Biotech and Digital? (Smaller Than You Think…)

Many people outside of biotech may wonder how the size of the biotech industry compares to the digital industry, and even biotech experts often don’t know the answer. Here we’ll take a look at how...

FIT Biotech Oy: Changes in FIT Biotech’s Board of Directors

FIT Biotech Oy Company release 7.1.2019 at 9:55 EET Changes in FIT Biotech’s Board of Directors FIT Biotech Oy’s (“Company”, FITBIO: FN Finland) Chairman of the Board of Direc...

Are Recent IPO Delays Bad News for European Biotech?

Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets — is this a sign that biotech stocks are underperforming?   Since the end of Octo...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Prestalia [marina biotech]

These highlights do not include all the information needed to use PRESTALIA tablets safely and effectively. See full prescribing information for PRESTALIA.PRESTALIA (perindopril arginine and amlodipin...

Pyridostigmine bromide [rising pharmaceuticals, inc.]

Pyridostigmine Bromide Extended-Release Tablets, 180 mg

Vivotif-b [rebel distributors corp]

Vivotif-B

Stelara [janssen biotech, inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) injection, for subcutaneous or int...

Ctx4 gel 5000 [oral biotech]

CariFree® CTx4 Gel 50001.1% (w/w) sodium fluoride

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Pevion Biotech develops a state-of-the-art vaccine against recurrent vulvovaginal candidiasis (VVC) caused by the pathogenic form of Candida albicans especially in pre-menopausal women of ...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

This phase I clinical study was designed to evaluate the safety of Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type)(E.Coli)(hereafter called HPV vaccine), manufact...

Companies [935 Associated Companies listed on BioPortfolio]

Pevion Biotech AG

Pevion Biotech AG is a fully independent Swiss vaccine company that develops innovative vaccines for unmet medical needs based on its clinically and commercially validated virosome technology. Its p...

Pevion Biotech Ltd.

Pevion Biotech successfully applies its proprietary virosome-based technology platforms to the development of efficient and safe prophylactic/therapeutic vaccines. Additionally, Pevion Biotech gives a...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

More Information about "Pevion Biotech AG" on BioPortfolio

We have published hundreds of Pevion Biotech AG news stories on BioPortfolio along with dozens of Pevion Biotech AG Clinical Trials and PubMed Articles about Pevion Biotech AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pevion Biotech AG Companies in our database. You can also find out about relevant Pevion Biotech AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...


Corporate Database Quicklinks



Searches Linking to this Company Record